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Introduction
The apolipoprotein E e4 allele (apo E4) is a well-established genetic risk factor for Alzheim-
er’s disease (AD).
1 Prospective studies have reported that depression is associated with subse-
quent dementia, including AD,
2-4 although some exceptions have been reported.
5 A review ar-
ticle stated that depression might be a prodromal phenomenon in the course of dementia.
6 
Furthermore, only the most severe syndromes and cases of depression were risk factors for 
dementia in cohort studies in China and the United Kingdom (UK).
7 A recent meta-analysis of 
11 cohort studies suggested that depression is an independent risk factor for AD.
8 In addition, 
apo E4 has been found to be associated with various vascular risks and diseases,
9,10 and it there-
fore may be associated with depression in late life, as age is closely related to vascular factors.
11 
We hypothesized that apo E4 and depression have a combined effect on dementia. In the re-
cently published Honolulu-Asia Aging Study, the individuals with apo E4 and depressive symp-
toms at baseline had a 7-fold greater risk of dementia after 6 years of follow-up compared with 
those with neither apo E4 nor depression.
12 
As this cohort included only men, the hypothesis has yet to be examined in women. Using 
data from a prospective community study of an older Korean population, this study investi-
gated the separate and combined effects of apo E4 and depression on the incidence of demen-
tia in both men and women.
ObjectiveaaGrowing evidence suggests the separate associations of apolipoprotein E e4 allele 
(apo E4) and depression with incident dementia. This study investigated the separate and combined 
effects of apo E4 and depression on the incidence of dementia in both men and women.
MethodsaaOf 625 elderly without dementia at baseline, 518 (83%) were followed over a 2.4-
year period and were assessed clinically for incident dementia. The apo E polymorphism was 
ascertained, and depression was identified using the Korean version of the Geriatric Depres-
sion Scale (KGDS). Covariates included age, gender, education, disability, alcohol history, physi-
cal activity, and vascular risk factors. 
ResultsaaThe incidence of dementia was significantly higher in elderly Koreans with both 
apo E4 and depression compared to those without both factors [adjusted odds ratio (95% CI)=5.85 
(1.77-19.38)]. This interaction was significant in men (p=0.049), but not in women (p=0.354).
ConclusionaaDepressed elderly people are at great risk for incident dementia in the presence 
of apo E4. Potential gender differences require further evaluation.
   Psychiatry Investig 2010;7:135-140
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Methods
Study outline and participants
A prospective community survey of late-life psychiatric 
morbidity was carried out in Gwangju, South Korea from 2001 
to 2003, in collaboration with the 10/66 International Demen-
tia Research Program in Developing Countries.
13 The study de-
sign has been described in several publications.
14,15 At baseline, 
all community residents aged 65 years or over within two geo-
graphic catchments were systematically identified from nation-
al registration lists and were approached to participate. A range 
of assessment scales and diagnostic instruments was adminis-
tered, and blood samples were obtained. Attempts were made 
to reassess all participants two years later (mean interval 2.4± 
0.3 years), when almost identical procedures to those at base-
line were performed. All participants gave formal written in-
formed consent at each examination. This study was approved 
by the Chonnam National University Hospital Institutional Re-
view Board.
Ascertainment of dementia
Identical assessments for dementia were carried out at base-
line and follow-up, including the Mini-Mental State Examina-
tion,
16 Instrumental Activities of Daily Living Scale,
17 Clinical 
Dementia Rating Scale,
18 collateral information on past histo-
ry, and a full physical and neurological examination. A commit-
tee of senior clinical researchers assigned consensus diagnoses, 
using standard criteria for dementia,
19 AD,
20 and vascular de-
mentia.
21 These were applied blindly to all other clinical infor-
mation, including the results of the blood assays, which were 
the focus of this analysis.
Apo E genotyping
Blood was drawn from the participants. DNA was amplified 
using the polymerase chain reaction, and the apo E genotype 
was determined, using standard reported procedures,
22 by a lab-
oratory specialist blind to the participants’ characteristics, and 
the results were categorized according to the presence or ab-
sence of apo E4.
Depression
Depression was evaluated using the Korean Geriatric Depres-
sion Scale (KGDS).
23 It comprises 30 questions, principally it-
ems from the Geriatric Depression Scale
24 supplemented by 
others from the Beck Depression Inventory,
25 Self-rating Depre-
ssion Scale,
26 Minnesota Multiphasic Personality Inventory 
Depression Scale,
27 and Center for Epidemiologic Studies De-
pression Scale.
28 
Its screening properties have been assessed previously against 
formal psychiatric diagnoses, and a 13/14 cut-off value was 
found to have an optimal balance of sensitivity (74%) and 
specificity (72%) for clinically significant depression.
23
Other covariates at baseline
Demographic data on age, gender, and education were record-
ed. Disability was measured using the World Health Organi-
zation Disability Assessment Schedule II (WHODAS II).
29 
Alcohol history (high alcohol consumption over the previous 
3 months was defined as >14 drinks/week for men, >7 drinks/
week for women) and daily physical activity (low activity was 
defined as a predominantly sedentary lifestyle) were ascertain-
ed. For vascular risk factors and disorders, a summary risk 
score was calculated by summing self-reported disorders (st-
roke, heart disease, hypertension, and diabetes), measured obe-
sity (body mass index >25 kg/m
2), and hypercholesterolemia 
(fasting cholesterol >200 mg/dL).
Statistical analysis
SPSS 12.0 software was used. For the analysis presented 
here, participants with dementia at baseline were excluded. In-
cident dementia was the dependent variable for all analyses. 
Baseline characteristics of the participants were compared by 
incident dementia status using the t-test, χ2 test, or Mann-Whit-
ney U-test as appropriate. To assess the individual associations 
of apo E4 and depression with incident dementia, logistic re-
gression analyses were conducted. To assess the combined ef-
fect, participants were categorized into four subgroups accord-
ing to the presence or absence of apo E4 and baseline depre-
ssion. The associations of apo E4 and depression with incident 
dementia were investigated using logistic regression analyses, 
treating the ‘absent apo E4-absent depression’ subgroup as the 
reference category before and after adjustment. The interaction 
between apo E4 and depression was evaluated by including an 
interaction term (apo E4×depression) in the models.
Results
Participant characteristics
Of the 732 participants at baseline, 625 did not have demen-
tia. Of these, 518 (83%) completed all evaluations at follow-up 
and comprised the sample for this analysis. Participants lost to 
follow-up (n=107) did not differ significantly compared to the 
analyzed sample for any baseline variable (data not shown). In 
the analyzed sample (n=518), incident cases of dementia were 
identified in 45 participants (8.7%): 34 (6.6%) AD, seven 
(1.4%) vascular dementia, and four ‘other’ dementia (0.8%). 
The baseline characteristics are described and compared by in-
cident dementia status in Table 1. Incident dementia was also 
significantly predicted by older age, lower education, more se-
vere disability, and less physical activity.
Separate effects of apo E4 and baseline 
depression on incident dementia
The individual associations of apo E4 and depression with 
incident dementia are summarized in Table 2. In the unadjust-JM Kim et al. 
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ed analyses, apo E4 and baseline depression were significant-
ly associated with incident dementia. The strengths of the asso-
ciations between apo E4 and incident dementia remained si-
gnificant in the adjusted models, whereas that between baseline 
depression and incident dementia fell below significance. Af-
ter further adjusting for the vascular risk score, the strengths of 
the associations fell slightly, but not substantially, as the odd ra-
tios [95% confidence intervals (CIs)] for the associations of apo 
E4 and depression were 1.74 (1.21-2.51) and 1.30 (0.61-2.79), 
respectively.
Combined effects of apo E4 and baseline 
depression on incident dementia
The univariate associations with incident dementia accord-
ing to the presence or absence of apo E4 and baseline depres-
sion are summarized in the second column of Table 3. Com-
pared to the ‘absent apo E4-absent depression’ subgroup, the 
‘present apo E4-present depression’ subgroup had a 9.2-fold 
greater risk of incident dementia. The multivariate associa-
tions with incident dementia and the interaction between apo 
E4 and depression in the models are summarized in the third 
column in Table 3. After adjusting for baseline age, education, 
disability, and physical activity, incident dementia remained 
significantly increased in the ‘present apo E4-present depres-
sion’ subgroup, although the strength of the association was 
weakened substantially. The associations in the other subgro-
ups did not reach statistical significance. The interaction terms 
between apo E4 and depression were borderline significant 
before adjustment and fell below significance after adjust-
ment. Further adjustment for the vascular risk score in all mo-
dels had no substantial effect on the results (data not shown).
Additional analyses
In the analyses stratified by gender using the same models, 
the adjusted odds ratios (95% CI) for incident dementia in the 
‘present apo E4-present depression’ subgroup compared to the 
‘absent apo E4-absent depression’ reference subgroup were 
17.51 (2.82-108.6) and 4.57 (1.31-15.98) in men and women, 
Table 1. Baseline characteristics by incident dementia status
Total sample
(N=518)
No incident dementia 
(N=473)
Incident dementia
(N=45)
Statistical  
coefficient
p-value*
Age, mean (SD) years 71.8 (5.1)0. 71.6 (4.9)0. 74.3 (5.7)00. t=-3.494 0.001
Female gender, N (%) 282 (54.4) 254 (53.7) 28 (62.2) χ2=1.203 0.273
Education, median (IQR) years 02 (0-6) 03 (0-6) 0 (0-2) Z=-3.973    <0.001
WHODAS II, median (IQR) score 2.2 (0-7). 2.1 (0-6). 5.4 (1-12). Z=-3.304 0.001
High alcohol intake, N (%) 155 (29.9) 141 (29.8) 14 (31.1) χ2=0.033 0.855
Low physical activity, N (%) 142 (27.4) 118 (24.9) 24 (53.3) χ2=16.64    <0.001
Vascular risk score, median (IQR) score 01 (0-2) 01 (0-2) 1 (1-2) Z=0.121 0.121
*t-test, χ2 test, or Mann–Whitney U-test, as appropriate. WHODAS II: World Health Organization Disability Assessment Scale II, SD: 
standard deviation, IQR: inter-quartile range
Table 2. Separate associations of the apolipoprotein E e4 allele (apo E4) and depression (Korean version of the Geriatric Depression Scale, 
scores >13) with incident dementia
Total sample
(N=518)
No incident dementia 
(N=4 73)
Incident dementia 
(N=45)
Odds ratio (95% CI)
Unadjusted Adjusted
Apo E4 allele, N (%) 089 (17.2) 74 (15.6) 14 (31.1) 2.44 (1.24-4.80) 1.75 (1.21-2.52)
Depression, N (%) 108 (20.8) 92 (19.5) 16 (35.6) 2.29 (1.19-4.38) 1.33 (0.62-2.84)
Adjusted for age, education, disability, and physical activity. CI: confidence interval
Table 3. Combined associations of apolipoprotein E e4 allele (apo E4) and depression (Korean version of the Geriatric Depression Scale >13) 
with incident dementia
N
Odds ratio (95% CI)
Unadjusted Adjusted
Absent apo E4-Absent depression 339 1.00 (ref)0000000 1.00 (ref)0000000
Absent apo E4-Present depression 071 1.61 (0.71-3.62)0 0.95 (0.39-2.34)0
Present apo E4-Absent depression 091 1.61 (0.66-3.92)0 1.98 (0.77-5.06)0
Present apo E4-Present depression 017 9.20 (3.25-26.06) 5.85 (1.77-19.38)
Apo E4×Depression, likelihood ratio p=0.0910000 p=0.160000
Adjusted for age, education, disability, and physical activity. CI: confidence interval138  Psychiatry Investig 2010;7:135-140
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respectively. The interaction terms between apo E4 and depres-
sion on incident dementia in the full adjusted model were sig-
nificant in men (p=0.049), but not in women (p=0.354). In an 
analysis with AD as the dependent variable, the adjusted odd 
ratios (95% CI) for incident dementia in the ‘present apo E4- 
present depression’ subgroup compared to the ‘absent apo E4- 
absent depression’ reference subgroup was 4.78 (1.59-14.40). 
The interaction terms between apo E4 and depression on inci-
dent AD in the full adjusted model was borderline significant 
(p=0.087).
Discussion
The principal finding of this prospective study of communi-
ty elderly was that the synergistic interaction between apo E4 
and depression has an effect on incident dementia. The inci-
dence of dementia was significantly higher in the ‘present apo 
E4-present depression’ subgroup compared to the ‘absent apo 
E4-absent depression’ subgroup. This interaction was signifi-
cant in men, but not in women. Similar interactions were found 
for AD as another independent variable.
The strengths of this study were that the design was prospec-
tive, the dementia diagnoses were kept blind with respect to 
other information and followed standard criteria, the analy-
ses considered various potential confounding factors, and the 
follow-up rate was reasonable and not different with respect 
to the exposures of interest. Limitations of the study were that 
the sample was relatively small for further stratification by gen-
der and dementia subtypes, incident dementia was evaluated 
over a relatively short period, and accurate timing of the onset 
of dementia was not possible. The annual incidence of demen-
tia in this sample was about 3.6%. This is comparable with the 
3-4% range reported in some studies,
30,31 but higher than the 
1-2% range suggested by others.
3,12 The relatively high prev-
alence of dementia observed at baseline
32 does not suggest that 
the observed high incidence was accounted for by previously 
missed cases. Another limitation was that the depressive parti-
cipants categorized by the KGDS cutoff might have had moder-
ate levels of depression, and the results may not be generaliz-
able to secondary care clinical samples with more severe synd-
romes. In addition, the baseline depression was unlikely to re-
flect full syndrome trajectories, and therefore may have miss-
ed changes in depressive status that occurred between the exa-
mination points.
Apo E4 was an independent risk factor for incident demen-
tia in this study. Apo E4 is an established risk factor for AD ba-
sed on numerous studies of various ethnicities and popula-
tions.
1 Apo E4 is also associated with cognitive decline in the 
elderly with normal cognition, which is salient to the findings 
of our study.
33
Previous studies of the associations between an earlier his-
tory of depression and later dementia have generally found sig-
nificant results
.8,34,35 However, the associations between base-
line depression and incident dementia in circumscribed coho-
rts have been controversial: some studies reported significant 
associations,
2,36 while other studies found significant associa-
tions only in men,
3,4 and yet other studies have found no signifi-
cant results.
5,30 Differences in study design, such as the follow-
up duration, participant characteristics, confounding factors 
considered, and methods of identifying depression, may explain 
the conflicting results. In our study based on self-report, base-
line depression was significantly associated with incident demen-
tia in the unadjusted analyses, but not after adjusting for the co-
variates. It has been suggested that vascular diseases are shared 
risk factors for depression and dementia.
37 In our study, howev-
er, the association between baseline depression and incident de-
mentia was explained by age, education, disability, and physi-
cal inactivity, rather than by vascular risk factors. Previous st-
udies also reported that the associations of depression with AD 
or mild cognitive impairment were independent of vascular ri-
sk factors.
4,38
Apo E4 not only increased the risk of dementia, but also mo-
dified the effects of other risk factors for dementia. The asso-
ciation between smaller head circumference and incident AD 
was particularly significant in the presence of apo E4.
39 The 
rate of cognitive decline associated with vascular diseases 
was increased by the presence of apo E4.
40 In keeping with 
these findings, one can also postulate that depression interacts 
with apo E4 in the incidence of dementia, although this has ra-
rely been tested. The recently published Honolulu-Asia Aging 
Study was the first to test this hypothesis. That study found that 
elderly people with both depressive symptoms and apo E4 at 
baseline had a markedly increased risk of dementia.
12 Similar 
results have been found in a few recent studies, although the 
dependent variable was not dementia. In a cohort of elderly 
persons with normal cognitive function, a synergistic interac-
tion between depression and apo E4 had an effect on the inci-
dence of mild cognitive impairment.
41 In another cohort with 
cognitively normal elders, the influence of depressive sympto-
ms on cognitive decline was greater among individuals with 
apo E4.
42 These synergistic effects might be explained at neu-
ropathological levels. The apo E4 accelerated the deposition of 
amyloid in the brain, one of the pathognomonic substances of 
AD. Depression could also lead to stress-induced neuroplastic 
changes in specific neural circuits, including the hippocampus, 
which is very important for memory function.
43 Therefore, the 
individuals with both apo E4 and depression might be parti-
cularly susceptible to developing dementia. Another plausible 
mechanism is that apo E4 could be a shared genetic factor for 
both depression and dementia. Apo E4 has been associated with 
various cardiovascular diseases,
9 which are closely related to 
both depression and dementia.
37 In our study, however, the in-
teraction between depression and apo E4 in incident dementia 
was not substantially explained by vascular risk factors.JM Kim et al. 
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Depression was significantly associated with dementia 
only in men, and not in women in a few studies,
3,4 whereas mo-
st other studies found no gender differences.
8 We also found no 
gender differences in the individual associations between de-
pression and incident dementia. With respect to the gender ef-
fects on the interaction between apo E4 and depression on in-
cident dementia, the only previous study to examine this issue 
could not test the hypothesis because that study included only 
male participants.
12 Our study allowed testing of this hypothe-
sis because the study sample consisted of both men and wom-
en. Consistent with previous results, the interaction was partic-
ularly significant in men and was not significant in women. Gen-
der differences in the neurobiology of depression
44 may expla-
in this finding. However, one should be cautious when draw-
ing conclusions from this finding, because the previous studies 
reporting interactions between apo E4 and depression in mild 
cognitive impairment or cognitive decline have not found gen-
der differences.
41,42 Further replication studies are needed.
Our findings suggest that elderly people with depressive 
symptoms are at greater risk for incident dementia in the pres-
ence of apo E4. Elderly individuals with both apo E4 and de-
pression should be monitored more carefully for early symp-
toms of dementia. Given that the genetic factor cannot be mo-
dified and that depression usually responds to pharmacologi-
cal and psychological management, depression should be tr-
eated appropriately in those with both susceptibility factors. 
Although the theme of this study is very important and relevant 
from a public health perspective, it has rarely been studied. Th-
erefore, the study should be replicated in various populations. 
The biological mechanisms underlying the interaction between 
apo E4 and depression have yet to be determined. In addition, 
possible gender differences in the interaction require further 
evaluation.
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